BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22495992)

  • 1. Discovery of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.
    Bunce K; Chu T; Surti U; Hogge WA; Peters DG
    Prenat Diagn; 2012 Jun; 32(6):542-9. PubMed ID: 22495992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.
    Chu T; Burke B; Bunce K; Surti U; Allen Hogge W; Peters DG
    Prenat Diagn; 2009 Nov; 29(11):1020-30. PubMed ID: 19650061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome fetal and maternal DNA methylation analysis using MeDIP-NGS for the identification of differentially methylated regions.
    Keravnou A; Ioannides M; Tsangaras K; Loizides C; Hadjidaniel MD; Papageorgiou EA; Kyriakou S; Antoniou P; Mina P; Achilleos A; Neofytou M; Kypri E; Sismani C; Koumbaris G; Patsalis PC
    Genet Res (Camb); 2016 Nov; 98():e15. PubMed ID: 27834155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21.
    Chim SS; Jin S; Lee TY; Lun FM; Lee WS; Chan LY; Jin Y; Yang N; Tong YK; Leung TY; Lau TK; Ding C; Chiu RW; Lo YM
    Clin Chem; 2008 Mar; 54(3):500-11. PubMed ID: 18202156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive prenatal diagnosis of trisomy 21 by dosage ratio of fetal chromosome-specific epigenetic markers in maternal plasma.
    Zhang M; Li T; Chen J; Li L; Zhou C; Wang Y; Liu W; Zhang Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):687. PubMed ID: 22038362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidate epigenetic biomarkers for non-invasive prenatal diagnosis of Down syndrome.
    Old RW; Crea F; Puszyk W; Hultén MA
    Reprod Biomed Online; 2007 Aug; 15(2):227-35. PubMed ID: 17697502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies.
    Papageorgiou EA; Fiegler H; Rakyan V; Beck S; Hulten M; Lamnissou K; Carter NP; Patsalis PC
    Am J Pathol; 2009 May; 174(5):1609-18. PubMed ID: 19349366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diagnosis of a hypermethylated full fragile X mutation in chorionic villi of a male fetus.
    Suzumori K; Yamauchi M; Seki N; Kondo I; Hori T
    J Med Genet; 1993 Sep; 30(9):785-7. PubMed ID: 8411077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma.
    Ou X; Wang H; Qu D; Chen Y; Gao J; Sun H
    Transfusion; 2014 Oct; 54(10):2523-33. PubMed ID: 24749853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach.
    Tong YK; Jin S; Chiu RW; Ding C; Chan KC; Leung TY; Yu L; Lau TK; Lo YM
    Clin Chem; 2010 Jan; 56(1):90-8. PubMed ID: 19850629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray.
    Yin A; Zhang X; Wu J; Du L; He T; Zhang X
    BMC Med Genomics; 2012 Jun; 5():26. PubMed ID: 22709530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of cytogenetic findings on chorionic villus sampling (CVS)--diagnostic consequences of CVS mosaicism and non-mosaic discrepancy in centres contributing to EUCROMIC 1986-1992.
    Hahnemann JM; Vejerslev LO
    Prenat Diagn; 1997 Sep; 17(9):801-20. PubMed ID: 9316125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylome profiling of maternal peripheral blood and placentas reveal potential fetal DNA markers for non-invasive prenatal testing.
    Xiang Y; Zhang J; Li Q; Zhou X; Wang T; Xu M; Xia S; Xing Q; Wang L; He L; Zhao X
    Mol Hum Reprod; 2014 Sep; 20(9):875-84. PubMed ID: 24996894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic identification of placental epigenetic signatures for the noninvasive prenatal detection of Edwards syndrome.
    Tsui DW; Lam YM; Lee WS; Leung TY; Lau TK; Lau ET; Tang MH; Akolekar R; Nicolaides KH; Chiu RW; Lo YM; Chim SS
    PLoS One; 2010 Nov; 5(11):e15069. PubMed ID: 21152411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and regulatory characterization of the placental epigenome at its maternal interface.
    Chu T; Handley D; Bunce K; Surti U; Hogge WA; Peters DG
    PLoS One; 2011 Feb; 6(2):e14723. PubMed ID: 21373191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing.
    Lau TK; Chen F; Pan X; Pooh RK; Jiang F; Li Y; Jiang H; Li X; Chen S; Zhang X
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1370-4. PubMed ID: 22070770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microarray-Based Analysis of Methylation Status of CpGs in Placental DNA and Maternal Blood DNA--Potential New Epigenetic Biomarkers for Cell Free Fetal DNA-Based Diagnosis.
    Hatt L; Aagaard MM; Graakjaer J; Bach C; Sommer S; Agerholm IE; Kølvraa S; Bojesen A
    PLoS One; 2015; 10(7):e0128918. PubMed ID: 26230497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
    Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
    Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Epigenetic Markers on Chromosome 21 for Noninvasive Prenatal Testing of Fetal Trisomy 21.
    Lee DE; Lim JH; Kim MH; Park SY; Ryu HM
    J Mol Diagn; 2016 May; 18(3):378-387. PubMed ID: 26947512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisulfite Conversion of DNA: Performance Comparison of Different Kits and Methylation Quantitation of Epigenetic Biomarkers that Have the Potential to Be Used in Non-Invasive Prenatal Testing.
    Leontiou CA; Hadjidaniel MD; Mina P; Antoniou P; Ioannides M; Patsalis PC
    PLoS One; 2015; 10(8):e0135058. PubMed ID: 26247357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.